SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-12-001496
Filing Date
2012-03-12
Accepted
2012-03-12 16:42:59
Documents
11
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 c68796_10q.htm 10-Q 730028
2 c68796_ex31-1.htm EX-31.1 8982
3 c68796_ex31-2.htm EX-31.2 9202
4 c68796_ex32-1.htm EX-32.1 3458
5 c68796_ex32-2.htm EX-32.2 3477
  Complete submission text file 0000930413-12-001496.txt   4334943

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enz-20120131.xml EX-101.INS 975889
7 enz-20120131.xsd EX-101.SCH 19038
8 XBRL CALCULATION FILE enz-20120131_cal.xml EX-101.CAL 34265
9 XBRL DEFINITION FILE enz-20120131_def.xml EX-101.DEF 87091
10 XBRL LABEL FILE enz-20120131_lab.xml EX-101.LAB 128427
11 XBRL PRESENTATION FILE enz-20120131_pre.xml EX-101.PRE 100731
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 12684445
SIC: 8071 Services-Medical Laboratories